Panos Fidias - Concepedia

Author

Panos Fidias

Massachusetts General Hospital

Also Known As

P Fidias, P. Fidias, P.M. Fidias, Panos Fidias, Panos M. Fidias

Publications

13K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Dana-Farber Cancer Institute Mass General Brigham Yale Cancer Center

About

Panos Fidias is an author at Massachusetts General Hospital specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.5K
2	Health Sciences	10	11	607
3	Pathology	9	9	745
4	Immunology	5	5	174
5	Allergy	1	1	47

Panos Fidias

Publications

12.4K

Citations

H-Index

Page 1

	Year	Citations
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, New England Journal of Medicine	2010	4.5K
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata, Science Translational Medicine	2011	3.5K
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib Eunice L. Kwak, Raffaella Sordella, Daphne W. Bell, Proceedings of the National Academy of Sciences	2005	951
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor <i>BRAF</i> gene mutations but lack mutations in <i>KRAS, NRAS,</i> or <i>MEK1</i> Kadoaki Ohashi, Lecia V. Sequist, Maria E. Arcila, Proceedings of the National Academy of Sciences	2012	434
Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer Panos Fidias, Shaker R. Dakhil, Alan P. Lyss, Journal of Clinical Oncology	2008	421
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice Lecia V. Sequist, Rebecca S. Heist, Alice T. Shaw, Annals of Oncology Non-small-cell Lung CancersCancer DetectionMedicinePathologyCancer Genomics	2011	351
Vaccination With Irradiated Autologous Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor Augments Antitumor Immunity in Some Patients With Metastatic Non–Small-Cell Lung Carcinoma Ravi Salgia, Thomas J. Lynch, Arthur T. Skarin, Journal of Clinical Oncology	2003	294
Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study Pasi A. Jänne, Sarada Gurubhagavatula, Beow Y. Yeap, Lung Cancer MedicineExpanded Access StudyCancer ManagementClinical Trials‘ Iressa ’	2004	197
Response to Treatment and Survival of Patients with Non-Small Cell Lung Cancer Undergoing Somatic<i>EGFR</i>Mutation Testing Lecia V. Sequist, Victoria A. Joshi, Pasi A. Jänne, The Oncologist	2007	159
Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer Michael Fanucchi, Frank V. Fossella, Robert J. Belt, Journal of Clinical Oncology	2006	155

Page 1